If you have S$40,000 to spare, here are four promising blue-chip stocks you can buy.
Browsing: Smart Analysis
With a recovery expected for the semiconductor sector next year, here are five stocks that could benefit.
These three REITs have conquered persistent headwinds this year to scale a 52-week high. Can their strong performance carry on into 2024?
The integrated healthcare player is going through a tough period but could see better earnings in the years to come.
These three REITs have defied the odds by posting a higher DPU for this year.
Here are three resilient blue-chip stocks with dividend yields of 5.7% and above.
It’s not how much interest rates have risen, but how fast.
We look at the latest commentary from the US central bank and whether Manulife US REIT’s unitholders approved its recapitalisation.
This edge lies in how you conduct yourself and whether you can keep your emotions in check.
If you are looking to add some growth to your portfolio, you should turn your attention to these four candidates.
Strategic reviews are aimed at unlocking value for shareholders.
Here are the five stocks that chalked up the best performance for this year.
We provide a quick round-up of the list of companies that look well-positioned to increase their dividends next year.
Here are four REITs with overseas assets that yield 8.6% or more.
The property giant is sounding an alarm to investors about falling valuations for its investment properties.
We size up the blue-chip stocks with the best performance this year.
We profile three Singapore stocks that could potentially reward shareholders with a special dividend.
What does a money-making portfolio look like?
We look at the latest retail sales figures for Singapore and explore a new cutting-edge treatment for genetic diseases.
We profile four REITs that could pay out a higher DPU next year.